Teekay LNG Partners LP EV/Sales
Was ist das EV/Sales von Teekay LNG Partners LP?
EV/Sales von Teekay LNG Partners LP ist 6.69
Was ist die Definition von EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales von Unternehmen in Industrials Sektor auf NYSE im Vergleich zu Teekay LNG Partners LP
Was macht Teekay LNG Partners LP?
Teekay LNG is one of the world's largest independent owners and operators of LNG carriers, providing LNG and LPG services primarily under long-term, fee-based charter contracts through its interests in 47 LNG carriers, 23 mid-size LPG carriers, and seven multi-gas carriers. The Partnership's ownership interests in these vessels range from 20 to 100 percent. In addition, the Partnership owns a 30 percent interest in a regasification terminal. Teekay LNG is a publicly-traded master limited partnership formed by Teekay Corporation as part of its strategy to expand its operations in the LNG and LPG shipping sectors.
Unternehmen mit ev/sales ähnlich Teekay LNG Partners LP
- Atmos hat EV/Sales von 6.67
- NHPC hat EV/Sales von 6.67
- Paliburg hat EV/Sales von 6.68
- InfraStrata Plc hat EV/Sales von 6.68
- Casino, Guichard-Perrachon SA hat EV/Sales von 6.69
- Henderson European Focus Trust Plc hat EV/Sales von 6.69
- Teekay LNG Partners LP hat EV/Sales von 6.69
- Income Fund hat EV/Sales von 6.70
- Neurocrine Biosciences hat EV/Sales von 6.70
- Adrabbit hat EV/Sales von 6.70
- Apollo Hospitals Enterprise hat EV/Sales von 6.70
- Diligent Media hat EV/Sales von 6.70
- Keboda hat EV/Sales von 6.70